Author

D. Gallagher

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Camus· 1 shared A. DellAglio· 1 shared A. Devaux· 1 shared A. Haydn· 1 shared A. J. Sercel· 1 shared A. Sinopoli· 1 shared A. Wiederkehr· 1 shared C. Divsalar· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Camus

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Accelerated physiology and increased energy expenditure in animals and humans with mitochondrial defects: A meta-analysis

A. J. Sercel, G. Sturm, E. D. Shaulson, D. Gallagher, M.-P. St-Onge, C. P. Kempes, H. Pontzer, M. Hirano, M. Picard

This study meta-analyzes energy expenditure in mitochondrial defect models, finding elevated energy costs in 51% of animal studies and similar trends in humans, suggesting hypermetabolism.

bioRxiv · Sep 9, 2023 · PreprintCell Biology

Epitope Engineered Human Haematopoietic Stem Cells are Shielded from CD123-targeted Immunotherapy

R. Marone, E. Landmann, A. Devaux, R. Lepore, D. Seyres, J. Zuin, T. Burgold, C. Engdahl, G. Capoferri, A. DellAglio, C. Larrue, F. Simonetta, J. Rositzka, M. Rhiel, G. Andrieux, , L. T. Jeker

This paper shows that epitope-engineered human hematopoietic stem cells are protected from CD123-targeted immunotherapy while maintaining functionality, offering a strategy for tumor-selective therapy.

bioRxiv · Jul 11, 2023Bioengineering